The efficacy of a DNA vaccine containing inserted and replicated regions of the E7 gene for treatment of HPV-16 induced tumors

被引：26

作者：

Brinkman, Joeli A.

Xu, Xuemei

Kast, W. Martin

机构：

[1] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA

[2] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Dept Biophys & Struct Biol, Beijing 100037, Peoples R China

来源：

VACCINE | 2007年 / 25卷 / 17期

关键词：

Human Papillomavirus (HPV); DNA vaccine; cervical cancer;

D O I：

10.1016/j.vaccine.2006.12.045

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

A majority of cervical cancers are associated with Human Papillomavirus (HPV)-16. A DNA vaccine (E7IR) was designed for prophylactic and therapeutic treatment of HPV-16+ tumors containing two repeats of the E7 gene to inactivate transformation and duplicate available epitopes. Mice were vaccinated then tumor challenged, or challenged and then immunized and monitored for tumor volume and survival. Splenocytes were utilized for in vivo CTL assays. The E7IR vaccine demonstrated decreased tumor Volume and enhanced survival in prophylactic and therapeutic experiments and improved CTL-mediated lysis. The E71R vaccine shows promise in prevention of tumor formation and elimination of established tumors. (c) 2007 Elsevier Ltd. All rights reserved.

引用

页码：3437 / 3444

页数：8

共 35 条

[1]

Brinkman JA, 2005, EUR J GYNAECOL ONCOL, V26, P129

[2] Antitumor efficacy of Venezuelan equine encephalitis virus replicon particles encoding mutated HPV16 E6 and E7 genes [J].

Cassetti, MC ;

McElhiney, SP ;

Shahabi, V ;

Pullen, JK ;

Le Poole, IC ;

Eiben, GL ;

Smith, LR ;

Kast, WM .

VACCINE, 2004, 22 (3-4) :520-527

[3] A synthetic E7 gene of human papillomavirus type 16 that yields enhanced expression of the protein in mammalian cells and is useful for DNA immunization studies [J].

Cid-Arregui, A ;

Juárez, V ;

zur Hausen, H .

JOURNAL OF VIROLOGY, 2003, 77 (08) :4928-4937

[4]

Da Silva Diane M, 2005, Am J Cancer (Auckl), V4, P207, DOI 10.2165/00024669-200504040-00001

[5] A polytope DNA vaccine elicits multiple effector and memory CTL responses and protects against human papillomavirus 16 E7-expressing tumour [J].

Doan, T ;

Herd, K ;

Ramshaw, I ;

Thomson, S ;

Tindle, RW .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2005, 54 (02) :157-171

[6] HUMAN PAPILLOMAVIRUS TYPE-16 (HPV-16) GENE-EXPRESSION AND DNA-REPLICATION IN CERVICAL NEOPLASIA - ANALYSIS BY INSITU HYBRIDIZATION [J].

DURST, M ;

GLITZ, D ;

SCHNEIDER, A ;

ZURHAUSEN, H .

VIROLOGY, 1992, 189 (01) :132-140

[7] Cervical cancer vaccines: Recent advances in HPV research [J].

Eiben, GL ;

Da Silva, DM ;

Fausch, SC ;

Le Poole, IC ;

Nishimura, MI ;

Kast, WM .

VIRAL IMMUNOLOGY, 2003, 16 (02) :111-121

[8]

Eiben GL, 2002, ADV CANCER RES, V86, P113

[9] VACCINATION WITH CYTOTOXIC T-LYMPHOCYTE EPITOPE-CONTAINING PEPTIDE PROTECTS AGAINST A TUMOR-INDUCED BY HUMAN PAPILLOMAVIRUS TYPE-16-TRANSFORMED CELLS [J].

FELTKAMP, MCW ;

SMITS, HL ;

VIERBOOM, MPM ;

MINNAAR, RP ;

DEJONGH, BM ;

DRIJFHOUT, JW ;

TERSCHEGGET, J ;

MELIEF, CJM ;

KAST, WM .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (09) :2242-2249

[10] Improving DNA vaccine potency by linking Marck's disease virus type 1 VP22 to an antigen [J].

Hung, CF ;

He, LM ;

Juang, J ;

Lin, TJ ;

Ling, M ;

Wu, TC .

JOURNAL OF VIROLOGY, 2002, 76 (06) :2676-2682

← 1 2 3 4 →